YaronAharonMoshelMDPhD

Brain & Spinal Tumor, Epilepsy Surgery, Pituitary Surgery, Skull Base

Medical Director of Neurosurgery, Atlantic Health System | Co-Director, Gerald J. Glasser Brain Tumor Center | Clinical Assistant Professor of Neurosurgery, NYU Langone Medical Center

Join to view full profile

Dr. Moshel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moshel's full profile

Already have an account?

Office
Overlook Medical Center - MAC II Building
11 Overlook Road, Suite 180
Summit, NJ 07901
Phone+1 973-993-7322

Fax+1 973-971-7315

Summary

Dr. Moshel specializes in advanced surgical techniques for removal of complex benign and malignant brain and spine tumors. Dr. Moshel is one of a select few surgeons who specialize in deep-seated brain tumors using technology that includes computer-guided navigation, awake intraoperative brain mapping, endoscopy, and microsurgery. He is also an expert in surgical approaches to the skull base and pituitary utilizing both microsurgical and minimally invasive endoscopic endonasal techniques. Dr. Moshel is actively involved in advancing the treatment of brain tumors and has been an investigator on several national Phase II-III brain tumor clinical trials and has authored numerous peer reviewed papers and book chapters.

Yaron Moshel, MD

Dr. Moshel is a neurosurgeon and co-director of The Gerald J. Glasser Brain Tumor Center at Atlantic Neuroscience Institute.

Education & Training

New York Presbyterian HospitalFellowship, Cerebrovascular & Skull Base Surgery, 2009 - 2010
NYU Grossman School of MedicineResidency, Neurological Surgery, 2004 - 2010
NYU Grossman School of MedicineFellowship, Neurosurgical Oncology, 2007 - 2008
NYU Grossman School of MedicineInternship, Transitional Year, 2003 - 2004
State University of New York Downstate Medical Center College of MedicineClass of 2003

Certifications & Licensure

NY State Medical License 2004 - 2026
NJ State Medical License 2010 - 2025
PA State Medical License 2009 - 2016
American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
Completed
Phase 1
Neurococognitive and Functioal Assessment of Patients With Brain Metastases Start of enrollment: 2013 Mar 01
Unknown status
Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Withdrawn
Phase 1
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Start of enrollment: 2015 Jan 30
Completed
Phase 1
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) Start of enrollment: 2017 Sep 21
Completed
Phase 2
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2015 May 04
Active, not recruiting
Phase 2
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) Start of enrollment: 2021 Nov 18
Active, not recruiting
Phase 2
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) Start of enrollment: 2022 Dec 07
Terminated
Phase 1, Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas Start of enrollment: 2015 Aug 01
Recruiting
Phase 2
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme Start of enrollment: 2021 May 18
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

173 citations
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...
Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim
JAMA Oncology. 2023-01-01
199 citations
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29
36 citations
Role of diffusion tensor imaging in resection of thalamic juvenile pilocytic astrocytoma.
Yaron A. Moshel, Robert E. Elliott, David Monoky, Jeffrey H. Wisoff
Journal of Neurosurgery. Pediatrics. 2009-12-01

Journal Articles

Diffuse Midline Gliomas with Subclonal H3F3A K27M Mutation and Mosaic H3.3 K27M Mutant Protein Expression
Kurt Jaeckle, Yaron A Moshel, Arie Perry, David A Solomon, Acta Neuropathologica

Press Mentions

Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
Overlook Medical Enrolling Patients for New Brain Tumor VaccineFebruary 24th, 2022
Overlook Medical Center Chosen as SURVIVE Trial Site, Enrolling Patients for New Brain Tumor VaccineFebruary 22nd, 2022
Join now to see all

Professional Memberships

External Links

Atlantic NeuroSurgical Specialistshttps://altairhealth.com/practitioner/yaron-a-moshel-md-phd/
Atlantic Health Systemhttps://findadoctor.atlantichealth.org/provider/Yaron+A+Moshel/642206
Glasser Brain Tumor Centerhttps://www.atlantichealth.org/conditions-treatments/neuroscience/brain-tumors.html